Freestone Grove Partners LP Invests $36.72 Million in Revvity Inc. $RVTY

Freestone Grove Partners LP bought a new position in shares of Revvity Inc. (NYSE:RVTY) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 330,003 shares of the company’s stock, valued at approximately $36,716,000. Freestone Grove Partners LP owned 0.30% of Revvity as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the company. AQR Capital Management LLC increased its stake in shares of Revvity by 5.2% in the first quarter. AQR Capital Management LLC now owns 8,449 shares of the company’s stock worth $883,000 after acquiring an additional 420 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Revvity by 6.7% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,776 shares of the company’s stock valued at $1,246,000 after purchasing an additional 744 shares during the last quarter. Millennium Management LLC grew its position in Revvity by 102.0% during the 1st quarter. Millennium Management LLC now owns 69,401 shares of the company’s stock worth $7,343,000 after purchasing an additional 35,048 shares during the period. Goldman Sachs Group Inc. raised its stake in shares of Revvity by 45.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 607,104 shares of the company’s stock valued at $64,232,000 after buying an additional 189,871 shares during the last quarter. Finally, Focus Partners Wealth raised its stake in shares of Revvity by 13.0% during the 1st quarter. Focus Partners Wealth now owns 7,028 shares of the company’s stock valued at $744,000 after buying an additional 811 shares during the last quarter. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Revvity Stock Performance

RVTY opened at $126.31 on Thursday. The firm’s fifty day simple moving average is $112.94 and its two-hundred day simple moving average is $100.82. Revvity Inc. has a 52-week low of $81.22 and a 52-week high of $126.90. The company has a market cap of $14.09 billion, a price-to-earnings ratio of 60.15, a PEG ratio of 2.27 and a beta of 1.07. The company has a quick ratio of 1.50, a current ratio of 1.80 and a debt-to-equity ratio of 0.36.

Revvity (NYSE:RVTY) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $1.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.20. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The company had revenue of $729.69 million for the quarter, compared to analysts’ expectations of $702.96 million. During the same period in the previous year, the firm posted $1.18 EPS. Revvity’s revenue was down 1.3% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Equities analysts anticipate that Revvity Inc. will post 5.36 earnings per share for the current fiscal year.

Revvity Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be issued a $0.07 dividend. The ex-dividend date is Friday, October 23rd. This represents a $0.28 dividend on an annualized basis and a yield of 0.2%. Revvity’s dividend payout ratio (DPR) is presently 13.33%.

Analyst Ratings Changes

Several analysts recently commented on RVTY shares. Robert W. Baird set a $117.00 target price on Revvity in a report on Wednesday, May 6th. JPMorgan Chase & Co. decreased their price target on Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a report on Wednesday, May 6th. TD Cowen restated a “buy” rating on shares of Revvity in a research report on Wednesday, July 15th. Barclays raised their price objective on shares of Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 7th. Finally, Wall Street Zen lowered shares of Revvity from a “buy” rating to a “hold” rating in a report on Sunday, August 16th. Three equities research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $108.36.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.